Home / Ranibizumab / Sweden
SE ATC S01LA04 · updated 2 Nov 2026
Ranibizumab shortage in Sweden
Is there a Ranibizumab shortage in Sweden?
Yes. As of 2 Nov 2026, 1 Ranibizumab product is reported short in Sweden, the first since 14 Jul 2025. The company estimate for the return is 31 Dec 2026. Main reason: not stated.
Also short in Canada. All countries.
Affected products in Sweden
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| SE | Ximluci 10 mg/ml Injektionsflaska, 1 dos (med filternål) | STADA Arzneimittel AG | 14 Jul 2025 | 31 Dec 2026 | Not stated |
Source
Läkemedelsverket (Swedish Medical Products Agency). Official list. Ongoing and announced shortages (restanmälningar) reported by companies; one row per pack.